Now Available: Diagnostics Year in Review 2023. Click to Download Report.
“The pandemic has accelerated the development of LetsGetChecked and the telehealth field by at least 3-5 years,” says Nick Naclerio, Ph.D., Founding Partner at Illumina Ventures. “We anticipated some tailwinds from COVID-19 testing. But we were blown away by the speed at which the company managed to scale to the challenge.”
“SQZ has developed an approach to cell therapy manufacturing that could have a major impact on the industry,” said Alexis Ji, Partner at Illumina Ventures. “We are excited about the prospects of creating cell therapies that are less expensive and can be delivered to patients much more rapidly.”
“Pattern’s next-gen clinical microbiology platform will set new standards in antibiotic susceptibility testing,” says Nick Naclerio, Illumina Ventures Founding Partner. In our latest Portfolio Company Spotlight, learn how Pattern Bioscience is revolutionizing bacterial diagnosis to fight antibiotic resistance by transforming pathogen identification and antibody susceptibility testing within ac...
“The results DNA Script has already obtained in making functional DNA today is impressive, but even more inspiring is the company’s vision of a tomorrow with manufacturing platforms focused upon massively parallel synthesis of longer, high-fidelity nucleic acids — a vision that holds great promise for completely transforming the molecular and synthetic biology solutions market while enabling th...
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
